Millennium Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-49,299
| Closed | -$737K | – | 7460 |
|
|
2022
Q4 | $737K | Sell |
49,299
-102,018
| -67% | -$1.41M | ﹤0.01% | 4436 |
|
|
2022
Q3 | $1.25M | Sell |
151,317
-491,933
| -76% | -$3.78M | ﹤0.01% | 4148 |
|
|
2022
Q2 | $4.22M | Sell |
643,250
-411,354
| -39% | -$1.99M | ﹤0.01% | 2976 |
|
|
2022
Q1 | $5.89M | Buy |
1,054,604
+154,636
| +17% | +$637K | ﹤0.01% | 2752 |
|
|
2021
Q4 | $4.22M | Buy |
899,968
+198,693
| +28% | +$1.23M | ﹤0.01% | 3079 |
|
|
2021
Q3 | $4.33M | Buy |
701,275
+220,290
| +46% | +$1.32M | ﹤0.01% | 3025 |
|
|
2021
Q2 | $3.17M | Buy |
480,985
+469,384
| +4,046% | +$3.24M | ﹤0.01% | 3371 |
|
|
2021
Q1 | $85K | Sell |
11,601
-73,026
| -86% | -$630K | ﹤0.01% | 5713 |
|
|
2020
Q4 | $488K | Buy |
+84,627
| New | +$484K | ﹤0.01% | 4214 |
|
|
2020
Q3 | – | Sell |
-118,694
| Closed | -$611K | – | 5062 |
|
|
2020
Q2 | $611K | Buy |
+118,694
| New | +$749K | ﹤0.01% | 3285 |
|
|
2020
Q1 | – | Sell |
-34,024
| Closed | -$212K | – | 4864 |
|
|
2019
Q4 | $212K | Sell |
34,024
-21,556
| -39% | -$159K | ﹤0.01% | 3848 |
|
|
2019
Q3 | $469K | Sell |
55,580
-287,110
| -84% | -$2.14M | ﹤0.01% | 3308 |
|
|
2019
Q2 | $2.31M | Buy |
+342,690
| New | +$2.94M | ﹤0.01% | 2319 |
|
|
2018
Q4 | – | Sell |
-55,476
| Closed | -$1.84M | – | 4410 |
|
|
2018
Q3 | $1.84M | Sell |
55,476
-195,726
| -78% | -$5.03M | ﹤0.01% | 2492 |
|
|
2018
Q2 | $5.68M | Sell |
251,202
-164,407
| -40% | -$3.9M | 0.01% | 1729 |
|
|
2018
Q1 | $12.1M | Buy |
415,609
+142,904
| +52% | +$4.18M | 0.02% | 1213 |
|
|
2017
Q4 | $7.61M | Buy |
272,705
+58,884
| +28% | +$1.83M | 0.01% | 1502 |
|
|
2017
Q3 | $7.8M | Buy |
213,821
+83,541
| +64% | +$2.58M | 0.01% | 1404 |
|
|
2017
Q2 | $2.89M | Buy |
130,280
+127,157
| +4,072% | +$1M | 0.01% | 1853 |
|
|
2017
Q1 | $18K | Buy |
+3,123
| New | +$22.6K | ﹤0.01% | 3430 |
|
|
2016
Q4 | – | Sell |
-1,480
| Closed | -$13K | – | 3903 |
|
|
2016
Q3 | $13K | Sell |
1,480
-264
| -15% | -$2.48K | ﹤0.01% | 3222 |
|
|
2016
Q2 | $17K | Buy |
+1,744
| New | +$16.8K | ﹤0.01% | 3106 |
|
|
2015
Q1 | – | Sell |
-6,513
| Closed | -$55K | – | 4306 |
|
|
2014
Q4 | $55K | Buy |
6,513
+1,513
| +30% | +$13.8K | ﹤0.01% | 3823 |
|
|
2014
Q3 | $55K | Buy |
+5,000
| New | +$63.6K | ﹤0.01% | 3594 |
|
|
2014
Q1 | – | Sell |
-34,029
| Closed | -$623K | – | 4071 |
|
|
2013
Q4 | $623K | Buy |
34,029
+3,464
| +11% | +$69.4K | ﹤0.01% | 2573 |
|
|
2013
Q3 | $630K | Sell |
30,565
-1,518
| -5% | -$34.8K | ﹤0.01% | 2396 |
|
|
2013
Q2 | $802K | Buy |
+32,083
| New | +$1.37M | ﹤0.01% | 2072 |
|
Millennium Management's AVEO Position: Q1 2023 in Review
Millennium Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 49,299 shares — an estimated $737K sold.
Millennium Management first reported a position in AVEO in Q2 2013 and held it in 27 quarters. The position peaked at $12.1M in Q1 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Millennium Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Millennium Management sold 49,299 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $737K.
- Millennium Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
- Millennium Management's AVEO Pharmaceuticals, Inc. position peaked at $12.1M in Q1 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.